Effects of magnesium biotinate supplementation on serum insulin, glucose and lipid parameters along with liver protein levels of lipid metabolism in rats (notice n° 755395)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 02359cam a2200301 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250123095918.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | Sahin, Kazim |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | Effects of magnesium biotinate supplementation on serum insulin, glucose and lipid parameters along with liver protein levels of lipid metabolism in rats |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2021.<br/> |
500 ## - GENERAL NOTE | |
General note | 58 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | The objective of this study was to investigate the effects of a novel form of biotin (magnesium biotinate) on serum glucose, lipid profile, and hepatic lipid metabolism-related protein levels in rats. Forty-two rats were divided into six groups and fed a standard diet-based egg white powdered diet supplemented with either d-biotin at 0.01, 1, or 100 mg/kg BW or magnesium biotinate at 0.01, 1, or 100 mg/kg BW for 35 days. Neither form of biotin influenced (p > 0.05) serum glucose or insulin concentrations. Serum total cholesterol and triglyceride decreased with biotin from both sources (p < 0.05). Concentrations were lower with magnesium biotinate when comparing the 1 mg/kg dose (p < 0.05). Serum, liver, and brain biotin and liver cyclic guanosine monophosphate (cGMP) concentrations were greater when rats were treated with magnesium biotinate versus d-biotin, particularly when comparing the 1 and 100 mg/kg dose groups (p < 0.05). Both biotin forms decreased the liver SREBP-1c and FAS and increased AMPK-α1, ACC-1, ACC-2, PCC, and MCC levels (p < 0.05). The magnitudes of responses were more emphasized with magnesium biotinate. Magnesium biotinate, compared with a commercial d-biotin, is more effective in reducing serum lipid concentrations and regulating protein levels of lipid metabolism-related biomarkers. |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | magnesium biotinate |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | glucose |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | D-biotin |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | insulin |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | lipid parameters |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Orhan, Cemal |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kucuk, Osman |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Erten, Fusun |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tuzcu, Mehmet |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sahin, Nurhan |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Perez Ojalvo, Sara |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Komorowski, James Richard |
Relator term | author |
786 0# - DATA SOURCE ENTRY | |
Note | Magnesium Research | 34 | 1 | 2021-01-01 | p. 9-19 | 0953-1424 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-magnesium-research-2021-1-page-9?lang=en&redirect-ssocas=7080">https://shs.cairn.info/revue-magnesium-research-2021-1-page-9?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux